CNS-5161
chemical compound
CNS-5161 is an NMDA receptor antagonist which was under development for the treatment of neuropathic pain and cancer pain but was never marketed. It is taken by intravenously or transdermally.
The drug is a highly potent and selective noncompetitive antagonist of the NMDA receptor via the ion channel or dizocilpine (MK-801) binding site, with an affinity (Ki) of 1.8 nM. It produces analgesic, anticonvulsant, and neuroprotective effects in rodents. There was also some dose-dependent mortality related to respiratory failure in rodents.
In humans, the drug was found to produce mild dissociative-like effects such as visual disturbances and derealization at assessed doses of 250 to 2,000 μg intravenously in clinical trials. In addition, it produced pronounced and dose-limiting hypertension.
The chemical synthesis of CNS-5161 and isotopologues has been described.
CNS-5161 was under development by CeNeS Pharmaceuticals. It reached phase 2 trials prior to the discontinuation of its development.
This brief starts where responsible research should: with the source description of “CNS-5161” as chemical compound. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the science & nature register because the source frames it as chemical compound. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Stable identifiers, scientific names and standards terminology offer the best bridge between this overview and specialist evidence. The source revision retrieved here is dated Feb 9, 2026. The linked authority identifier is Q27095700. None of the 0 selected statements returned an explicit reference.
Scientific names, classifications and consensus can change while older terminology persists in catalogues and historical literature. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “CNS-5161”, its source revision and the description used here.
- Expand the search: follow CNS-5161 primary sources, CNS-5161 archive and CNS-5161 research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “CNS-5161”?
- Which observation, specimen, dataset or publication supports the account?
- Is the terminology current, historical or disputed?
Search terms from this dossier
This entry incorporates text from “CNS-5161” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.